Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA515376
Max Phase: Preclinical
Molecular Formula: C25H27FN3O8P
Molecular Weight: 547.48
Molecule Type: Small molecule
Associated Items:
ID: ALA515376
Max Phase: Preclinical
Molecular Formula: C25H27FN3O8P
Molecular Weight: 547.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2cccnc2=O)[C@@H](F)[C@@H]1O)Oc1ccccc1)C(=O)OCc1ccccc1
Standard InChI: InChI=1S/C25H27FN3O8P/c1-17(24(31)34-15-18-9-4-2-5-10-18)28-38(33,37-19-11-6-3-7-12-19)35-16-20-22(30)21(26)23(36-20)29-14-8-13-27-25(29)32/h2-14,17,20-23,30H,15-16H2,1H3,(H,28,33)/t17-,20+,21-,22+,23+,38?/m0/s1
Standard InChI Key: RBGXXFYMRVDADE-VFRMFQDASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 547.48 | Molecular Weight (Monoisotopic): 547.1520 | AlogP: 2.76 | #Rotatable Bonds: 11 |
Polar Surface Area: 138.21 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.24 | CX Basic pKa: | CX LogP: 2.16 | CX LogD: 2.16 |
Aromatic Rings: 3 | Heavy Atoms: 38 | QED Weighted: 0.27 | Np Likeness Score: 0.01 |
1. Yoo CB, Valente R, Congiatu C, Gavazza F, Angel A, Siddiqui MA, Jones PA, McGuigan C, Marquez VE.. (2008) Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2'-deoxyzebularine., 51 (23): [PMID:19006382] [10.1021/jm8005965] |
Source(1):